Moolec Science (MLEC) Other Operating Expenses (2022 - 2024)
Moolec Science's (MLEC) quarterly Other Operating Expenses came in at -$703265.0 in Q2 2024, up 78.72% quarter-over-quarter from -$3.3 million in Q2 2022.
Moolec Science (MLEC) Other Operating Expenses (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Other Operating Expenses across 2 years of filings, most recently posting -$703265.0 for Q2 2024.
- Other Operating Expenses for Q2 2024 came in at -$703265.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was -$703265.0 (changed 0.0% YoY), and the FY2024 annual result was -$703265.0, down 166.64% from the prior year.
- Other Operating Expenses came in at -$703265.0 for Q2 2024 at Moolec Science, up from -$3.3 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of -$703265.0 in Q2 2024 to a low of -$3.3 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -703,265.00 |
| Jun 30, 2022 | -3.30 Mn |